Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
12/16/2014
Stemline Initiates SL-401 Trial in Four Rare Myeloproliferative Neoplasms
12/5/2014
Stemline Announces Multiple Preclinical Presentations at the 2014 ASH Meeting
11/12/2014
Stemline Reports 3Q14 Financial Results and Provides Corporate Update
Copyright 2014 - Stemline Therapeutics, Inc. All rights reserved
Stemline